ID   SSDH_HUMAN              Reviewed;         535 AA.
AC   P51649; B2RD26; G5E949; Q546H9; Q8N3W6;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 2.
DT   10-MAY-2017, entry version 169.
DE   RecName: Full=Succinate-semialdehyde dehydrogenase, mitochondrial;
DE            EC=1.2.1.24;
DE   AltName: Full=Aldehyde dehydrogenase family 5 member A1;
DE   AltName: Full=NAD(+)-dependent succinic semialdehyde dehydrogenase;
DE   Flags: Precursor;
GN   Name=ALDH5A1; Synonyms=SSADH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Lymphocyte;
RX   PubMed=9683595; DOI=10.1086/301964;
RA   Chambliss K.L., Hinson D.D., Trettel F., Malaspina P., Novelletto A.,
RA   Jakobs C., Gibson K.M.;
RT   "Two exon-skipping mutations as the molecular basis of succinic
RT   semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria).";
RL   Am. J. Hum. Genet. 63:399-408(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), NUCLEOTIDE SEQUENCE [MRNA] OF
RP   69-535 (ISOFORM 2), ALTERNATIVE SPLICING, AND VARIANT SER-372.
RC   TISSUE=B-cell;
RX   PubMed=12208142; DOI=10.1016/S1096-7192(02)00105-1;
RA   Blasi P., Boyl P.P., Ledda M., Novelletto A., Gibson K.M., Jakobs C.,
RA   Hogema B., Akaboshi S., Loreni F., Malaspina P.;
RT   "Structure of human succinic semialdehyde dehydrogenase gene:
RT   identification of promoter region and alternatively processed
RT   isoforms.";
RL   Mol. Genet. Metab. 76:348-362(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   TYR-180.
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 213-535 (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=7814412; DOI=10.1074/jbc.270.1.461;
RA   Chambliss K.L., Caudle D.L., Hinson D.D., Moomaw C.R., Slaughter C.A.,
RA   Jakobs C., Gibson K.M.;
RT   "Molecular cloning of the mature NAD(+)-dependent succinic
RT   semialdehyde dehydrogenase from rat and human. cDNA isolation,
RT   evolutionary homology, and tissue expression.";
RL   J. Biol. Chem. 270:461-467(1995).
RN   [8]
RP   SUBUNIT.
RC   TISSUE=Brain;
RX   PubMed=9059628;
RA   Trettel F., Malaspina P., Jodice C., Novelletto A., Slaughter C.A.,
RA   Caudle D.L., Hinson D.D., Chambliss K.L., Gibson K.M.;
RT   "Human succinic semialdehyde dehydrogenase. Molecular cloning and
RT   chromosomal localization.";
RL   Adv. Exp. Med. Biol. 414:253-260(1997).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-126, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-499, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 49-535 IN COMPLEX WITH
RP   PRODUCT AND ADP, FUNCTION, ENZYME REGULATION, DISULFIDE BOND, AND
RP   MUTAGENESIS OF ARG-213; ARG-334; CYS-342 AND SER-498.
RX   PubMed=19300440; DOI=10.1038/emboj.2009.40;
RA   Kim Y.-G., Lee S., Kwon O.-S., Park S.-Y., Lee S.-J., Park B.-J.,
RA   Kim K.-J.;
RT   "Redox-switch modulation of human SSADH by dynamic catalytic loop.";
RL   EMBO J. 28:959-968(2009).
RN   [13]
RP   VARIANTS SSADHD GLU-268 AND ASP-409.
RX   PubMed=11243727; DOI=10.1006/mgme.2000.3145;
RA   Hogema B.M., Akaboshi S., Taylor M., Salomons G.S., Jakobs C.,
RA   Schutgens R.B., Wilcken B., Worthington S., Maropoulos G., Grompe M.,
RA   Gibson K.M.;
RT   "Prenatal diagnosis of succinic semialdehyde dehydrogenase deficiency:
RT   increased accuracy employing DNA, enzyme, and metabolite analyses.";
RL   Mol. Genet. Metab. 72:218-222(2001).
RN   [14]
RP   VARIANT SSADHD GLU-487.
RX   PubMed=11901270; DOI=10.1159/000048603;
RA   Aoshima T., Kajita M., Sekido Y., Ishiguro Y., Tsuge I., Kimura M.,
RA   Yamaguchi S., Watanabe K., Shimokata K., Niwa T.;
RT   "Mutation analysis in a patient with succinic semialdehyde
RT   dehydrogenase deficiency: a compound heterozygote with 103-121del and
RT   1460T>A of the ALDH5A1 gene.";
RL   Hum. Hered. 53:42-44(2002).
RN   [15]
RP   VARIANTS SSADHD PHE-93; ARG-176; TYR-223; MET-233; SER-255; GLU-268;
RP   LYS-335; GLN-382; LEU-382; ASP-409 AND ARG-533, VARIANTS ARG-36;
RP   TYR-180; LEU-182; SER-237 AND ILE-406, AND CHARACTERIZATION OF
RP   VARIANTS ARG-36; PHE-93; ARG-176; TYR-180; LEU-182; TYR-223; MET-233;
RP   SER-237; SER-255; GLU-268; LYS-335; LEU-382; ASP-409 AND ARG-533.
RX   PubMed=14635103; DOI=10.1002/humu.10288;
RA   Akaboshi S., Hogema B.M., Novelletto A., Malaspina P., Salomons G.S.,
RA   Maropoulos G.D., Jakobs C., Grompe M., Gibson K.M.;
RT   "Mutational spectrum of the succinate semialdehyde dehydrogenase
RT   (ALDH5A1) gene and functional analysis of 27 novel disease-causing
RT   mutations in patients with SSADH deficiency.";
RL   Hum. Mutat. 22:442-450(2003).
CC   -!- FUNCTION: Catalyzes one step in the degradation of the inhibitory
CC       neurotransmitter gamma-aminobutyric acid (GABA).
CC       {ECO:0000269|PubMed:19300440}.
CC   -!- CATALYTIC ACTIVITY: Succinate semialdehyde + NAD(+) + H(2)O =
CC       succinate + NADH.
CC   -!- ENZYME REGULATION: Redox-regulated. Inhibited under oxydizing
CC       conditions. Inhibited by hydrogen peroxide H(2)O(2).
CC       {ECO:0000269|PubMed:19300440}.
CC   -!- PATHWAY: Amino-acid degradation; 4-aminobutanoate degradation.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:19300440,
CC       ECO:0000269|PubMed:9059628}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P51649-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P51649-2; Sequence=VSP_045231;
CC   -!- TISSUE SPECIFICITY: Brain, pancreas, heart, liver, skeletal muscle
CC       and kidney. Lower in placenta.
CC   -!- DISEASE: Succinic semialdehyde dehydrogenase deficiency (SSADHD)
CC       [MIM:271980]: A rare inborn error of 4-aminobutyric acid (GABA)
CC       metabolism, which leads to accumulation of 4-hydroxybutyric acid
CC       in physiologic fluids of patients. The disease is clinically
CC       characterized by developmental delay, hypotonia, mental
CC       retardation, ataxia, seizures, hyperkinetic behavior, aggression,
CC       and sleep disturbances. {ECO:0000269|PubMed:11243727,
CC       ECO:0000269|PubMed:11901270, ECO:0000269|PubMed:14635103}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the aldehyde dehydrogenase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y11192; CAA72076.1; -; mRNA.
DR   EMBL; AJ427354; CAD20883.2; -; mRNA.
DR   EMBL; AJ427355; CAD20884.1; -; mRNA.
DR   EMBL; AK315380; BAG37773.1; -; mRNA.
DR   EMBL; AL031230; CAA20248.1; -; Genomic_DNA.
DR   EMBL; CH471087; EAW55452.1; -; Genomic_DNA.
DR   EMBL; CH471087; EAW55453.1; -; Genomic_DNA.
DR   EMBL; BC034321; AAH34321.1; -; mRNA.
DR   EMBL; L34820; AAA67057.1; -; mRNA.
DR   CCDS; CCDS4555.1; -. [P51649-1]
DR   CCDS; CCDS4556.1; -. [P51649-2]
DR   PIR; A55773; A55773.
DR   RefSeq; NP_001071.1; NM_001080.3. [P51649-1]
DR   RefSeq; NP_733936.1; NM_170740.1. [P51649-2]
DR   UniGene; Hs.371723; -.
DR   PDB; 2W8N; X-ray; 2.00 A; A=49-535.
DR   PDB; 2W8O; X-ray; 3.40 A; A=49-535.
DR   PDB; 2W8P; X-ray; 2.30 A; A=49-535.
DR   PDB; 2W8Q; X-ray; 2.40 A; A=49-535.
DR   PDB; 2W8R; X-ray; 2.40 A; A=49-535.
DR   PDBsum; 2W8N; -.
DR   PDBsum; 2W8O; -.
DR   PDBsum; 2W8P; -.
DR   PDBsum; 2W8Q; -.
DR   PDBsum; 2W8R; -.
DR   ProteinModelPortal; P51649; -.
DR   SMR; P51649; -.
DR   BioGrid; 113645; 23.
DR   IntAct; P51649; 3.
DR   MINT; MINT-6950845; -.
DR   STRING; 9606.ENSP00000314649; -.
DR   BindingDB; P51649; -.
DR   ChEMBL; CHEMBL1911; -.
DR   DrugBank; DB00534; Chlormerodrin.
DR   DrugBank; DB00157; NADH.
DR   DrugBank; DB00139; Succinic acid.
DR   DrugBank; DB00313; Valproic Acid.
DR   GuidetoPHARMACOLOGY; 2466; -.
DR   iPTMnet; P51649; -.
DR   PhosphoSitePlus; P51649; -.
DR   SwissPalm; P51649; -.
DR   BioMuta; ALDH5A1; -.
DR   DMDM; 7531278; -.
DR   EPD; P51649; -.
DR   PaxDb; P51649; -.
DR   PeptideAtlas; P51649; -.
DR   PRIDE; P51649; -.
DR   DNASU; 7915; -.
DR   Ensembl; ENST00000348925; ENSP00000314649; ENSG00000112294. [P51649-2]
DR   Ensembl; ENST00000357578; ENSP00000350191; ENSG00000112294. [P51649-1]
DR   GeneID; 7915; -.
DR   KEGG; hsa:7915; -.
DR   CTD; 7915; -.
DR   DisGeNET; 7915; -.
DR   GeneCards; ALDH5A1; -.
DR   GeneReviews; ALDH5A1; -.
DR   HGNC; HGNC:408; ALDH5A1.
DR   HPA; HPA029715; -.
DR   HPA; HPA029716; -.
DR   MalaCards; ALDH5A1; -.
DR   MIM; 271980; phenotype.
DR   MIM; 610045; gene.
DR   neXtProt; NX_P51649; -.
DR   OpenTargets; ENSG00000112294; -.
DR   Orphanet; 22; 4-hydroxybutyric aciduria.
DR   PharmGKB; PA24702; -.
DR   eggNOG; KOG2451; Eukaryota.
DR   eggNOG; COG1012; LUCA.
DR   GeneTree; ENSGT00840000129936; -.
DR   HOGENOM; HOG000271509; -.
DR   HOVERGEN; HBG108515; -.
DR   InParanoid; P51649; -.
DR   KO; K00139; -.
DR   OMA; LGPLINN; -.
DR   PhylomeDB; P51649; -.
DR   TreeFam; TF352906; -.
DR   BioCyc; MetaCyc:HS03550-MONOMER; -.
DR   BRENDA; 1.2.1.24; 2681.
DR   Reactome; R-HSA-916853; Degradation of GABA.
DR   SABIO-RK; P51649; -.
DR   UniPathway; UPA00733; -.
DR   EvolutionaryTrace; P51649; -.
DR   GeneWiki; Aldehyde_dehydrogenase_5_family,_member_A1; -.
DR   GenomeRNAi; 7915; -.
DR   PRO; PR:P51649; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000112294; -.
DR   CleanEx; HS_ALDH5A1; -.
DR   ExpressionAtlas; P51649; baseline and differential.
DR   Genevisible; P51649; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IC:UniProtKB.
DR   GO; GO:0004777; F:succinate-semialdehyde dehydrogenase (NAD+) activity; IDA:UniProtKB.
DR   GO; GO:0009013; F:succinate-semialdehyde dehydrogenase [NAD(P)+] activity; IEA:InterPro.
DR   GO; GO:0006083; P:acetate metabolic process; ISS:UniProtKB.
DR   GO; GO:0007417; P:central nervous system development; IMP:UniProtKB.
DR   GO; GO:0006681; P:galactosylceramide metabolic process; ISS:UniProtKB.
DR   GO; GO:0009450; P:gamma-aminobutyric acid catabolic process; IDA:UniProtKB.
DR   GO; GO:0006006; P:glucose metabolic process; ISS:UniProtKB.
DR   GO; GO:0006678; P:glucosylceramide metabolic process; IEA:Ensembl.
DR   GO; GO:0006536; P:glutamate metabolic process; ISS:UniProtKB.
DR   GO; GO:0006541; P:glutamine metabolic process; ISS:UniProtKB.
DR   GO; GO:0006749; P:glutathione metabolic process; ISS:UniProtKB.
DR   GO; GO:0006650; P:glycerophospholipid metabolic process; ISS:UniProtKB.
DR   GO; GO:0042135; P:neurotransmitter catabolic process; ISS:UniProtKB.
DR   GO; GO:0009791; P:post-embryonic development; IEA:Ensembl.
DR   GO; GO:0051289; P:protein homotetramerization; IDA:UniProtKB.
DR   GO; GO:0022904; P:respiratory electron transport chain; ISS:UniProtKB.
DR   GO; GO:0046459; P:short-chain fatty acid metabolic process; ISS:UniProtKB.
DR   GO; GO:0006105; P:succinate metabolic process; ISS:UniProtKB.
DR   Gene3D; 3.40.605.10; -; 1.
DR   InterPro; IPR016161; Ald_DH/histidinol_DH.
DR   InterPro; IPR016160; Ald_DH_CS_CYS.
DR   InterPro; IPR029510; Ald_DH_CS_GLU.
DR   InterPro; IPR016162; Ald_DH_N.
DR   InterPro; IPR015590; Aldehyde_DH_dom.
DR   InterPro; IPR010102; Succ_semiAld_DH.
DR   Pfam; PF00171; Aldedh; 1.
DR   SUPFAM; SSF53720; SSF53720; 1.
DR   TIGRFAMs; TIGR01780; SSADH; 1.
DR   PROSITE; PS00070; ALDEHYDE_DEHYDR_CYS; 1.
DR   PROSITE; PS00687; ALDEHYDE_DEHYDR_GLU; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Disease mutation; Disulfide bond; Mitochondrion; NAD; Oxidoreductase;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transit peptide.
FT   TRANSIT       1     47       Mitochondrion. {ECO:0000255}.
FT   CHAIN        48    535       Succinate-semialdehyde dehydrogenase,
FT                                mitochondrial.
FT                                /FTId=PRO_0000007184.
FT   NP_BIND     228    231       NAD.
FT   NP_BIND     284    289       NAD.
FT   ACT_SITE    306    306       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10007, ECO:0000255|PROSITE-
FT                                ProRule:PRU10008}.
FT   ACT_SITE    340    340       Nucleophile. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10007, ECO:0000255|PROSITE-
FT                                ProRule:PRU10008}.
FT   BINDING     213    213       NAD.
FT   BINDING     213    213       Substrate.
FT   BINDING     334    334       Substrate.
FT   BINDING     498    498       Substrate.
FT   SITE        205    205       Transition state stabilizer.
FT                                {ECO:0000250}.
FT   MOD_RES     126    126       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     126    126       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BWF0}.
FT   MOD_RES     135    135       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BWF0}.
FT   MOD_RES     184    184       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BWF0}.
FT   MOD_RES     265    265       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BWF0}.
FT   MOD_RES     265    265       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BWF0}.
FT   MOD_RES     365    365       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BWF0}.
FT   MOD_RES     402    402       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BWF0}.
FT   MOD_RES     411    411       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BWF0}.
FT   MOD_RES     499    499       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   DISULFID    340    342       In inhibited form.
FT                                {ECO:0000269|PubMed:19300440}.
FT   VAR_SEQ     242    242       E -> EVNQGFLLDLDPLL (in isoform 2).
FT                                {ECO:0000303|PubMed:12208142}.
FT                                /FTId=VSP_045231.
FT   VARIANT      36     36       G -> R (in dbSNP:rs4646832).
FT                                {ECO:0000269|PubMed:14635103}.
FT                                /FTId=VAR_026227.
FT   VARIANT      93     93       C -> F (in SSADHD; 3% of activity;
FT                                dbSNP:rs765561257).
FT                                {ECO:0000269|PubMed:14635103}.
FT                                /FTId=VAR_026199.
FT   VARIANT     176    176       G -> R (in SSADHD; <1% of activity;
FT                                dbSNP:rs72552281).
FT                                {ECO:0000269|PubMed:14635103}.
FT                                /FTId=VAR_026200.
FT   VARIANT     180    180       H -> Y (83% of activity;
FT                                dbSNP:rs2760118).
FT                                {ECO:0000269|PubMed:14635103,
FT                                ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_016758.
FT   VARIANT     182    182       P -> L (48% of activity;
FT                                dbSNP:rs3765310).
FT                                {ECO:0000269|PubMed:14635103}.
FT                                /FTId=VAR_016759.
FT   VARIANT     223    223       C -> Y (in SSADHD; 5% of activity;
FT                                dbSNP:rs72552282).
FT                                {ECO:0000269|PubMed:14635103}.
FT                                /FTId=VAR_026201.
FT   VARIANT     233    233       T -> M (in SSADHD; 4% of activity).
FT                                {ECO:0000269|PubMed:14635103}.
FT                                /FTId=VAR_026202.
FT   VARIANT     237    237       A -> S (65% of activity;
FT                                dbSNP:rs62621664).
FT                                {ECO:0000269|PubMed:14635103}.
FT                                /FTId=VAR_026228.
FT   VARIANT     255    255       N -> S (in SSADHD; 17% of activity;
FT                                dbSNP:rs145087265).
FT                                {ECO:0000269|PubMed:14635103}.
FT                                /FTId=VAR_026203.
FT   VARIANT     268    268       G -> E (in SSADHD; <1% of activity;
FT                                dbSNP:rs375628463).
FT                                {ECO:0000269|PubMed:11243727,
FT                                ECO:0000269|PubMed:14635103}.
FT                                /FTId=VAR_026204.
FT   VARIANT     335    335       N -> K (in SSADHD; 1% of activity;
FT                                dbSNP:rs72552283).
FT                                {ECO:0000269|PubMed:14635103}.
FT                                /FTId=VAR_026205.
FT   VARIANT     372    372       N -> S. {ECO:0000269|PubMed:12208142}.
FT                                /FTId=VAR_069047.
FT   VARIANT     382    382       P -> L (in SSADHD; 2% of activity).
FT                                {ECO:0000269|PubMed:14635103}.
FT                                /FTId=VAR_026206.
FT   VARIANT     382    382       P -> Q (in SSADHD).
FT                                {ECO:0000269|PubMed:14635103}.
FT                                /FTId=VAR_026207.
FT   VARIANT     406    406       V -> I (in dbSNP:rs143741652).
FT                                {ECO:0000269|PubMed:14635103}.
FT                                /FTId=VAR_026229.
FT   VARIANT     409    409       G -> D (in SSADHD; <1% of activity;
FT                                dbSNP:rs118203984).
FT                                {ECO:0000269|PubMed:11243727,
FT                                ECO:0000269|PubMed:14635103}.
FT                                /FTId=VAR_026208.
FT   VARIANT     487    487       V -> E (in SSADHD).
FT                                {ECO:0000269|PubMed:11901270}.
FT                                /FTId=VAR_026209.
FT   VARIANT     533    533       G -> R (in SSADHD; <1% of activity;
FT                                dbSNP:rs72552284).
FT                                {ECO:0000269|PubMed:14635103}.
FT                                /FTId=VAR_026210.
FT   MUTAGEN     213    213       R->A: Reduces catalytic activity to less
FT                                than 15% of wild-type.
FT                                {ECO:0000269|PubMed:19300440}.
FT   MUTAGEN     334    334       R->A: Reduces catalytic activity to less
FT                                than 15% of wild-type.
FT                                {ECO:0000269|PubMed:19300440}.
FT   MUTAGEN     342    342       C->A: Loss of regulation by redox state.
FT                                {ECO:0000269|PubMed:19300440}.
FT   MUTAGEN     498    498       S->A: Reduces catalytic activity to less
FT                                than 15% of wild-type.
FT                                {ECO:0000269|PubMed:19300440}.
FT   TURN         56     58       {ECO:0000244|PDB:2W8P}.
FT   STRAND       62     65       {ECO:0000244|PDB:2W8N}.
FT   STRAND       68     70       {ECO:0000244|PDB:2W8N}.
FT   STRAND       75     79       {ECO:0000244|PDB:2W8N}.
FT   TURN         81     83       {ECO:0000244|PDB:2W8N}.
FT   STRAND       86     91       {ECO:0000244|PDB:2W8N}.
FT   HELIX        95    112       {ECO:0000244|PDB:2W8N}.
FT   HELIX       117    133       {ECO:0000244|PDB:2W8N}.
FT   HELIX       135    146       {ECO:0000244|PDB:2W8N}.
FT   HELIX       150    170       {ECO:0000244|PDB:2W8N}.
FT   HELIX       171    173       {ECO:0000244|PDB:2W8N}.
FT   STRAND      177    179       {ECO:0000244|PDB:2W8N}.
FT   STRAND      187    194       {ECO:0000244|PDB:2W8N}.
FT   STRAND      197    201       {ECO:0000244|PDB:2W8N}.
FT   STRAND      204    206       {ECO:0000244|PDB:2W8N}.
FT   HELIX       209    221       {ECO:0000244|PDB:2W8N}.
FT   STRAND      224    228       {ECO:0000244|PDB:2W8N}.
FT   HELIX       235    247       {ECO:0000244|PDB:2W8N}.
FT   STRAND      253    256       {ECO:0000244|PDB:2W8N}.
FT   HELIX       261    271       {ECO:0000244|PDB:2W8N}.
FT   STRAND      277    284       {ECO:0000244|PDB:2W8N}.
FT   HELIX       286    297       {ECO:0000244|PDB:2W8N}.
FT   TURN        298    300       {ECO:0000244|PDB:2W8N}.
FT   STRAND      302    307       {ECO:0000244|PDB:2W8N}.
FT   STRAND      309    315       {ECO:0000244|PDB:2W8N}.
FT   STRAND      317    319       {ECO:0000244|PDB:2W8O}.
FT   HELIX       321    332       {ECO:0000244|PDB:2W8N}.
FT   HELIX       334    337       {ECO:0000244|PDB:2W8P}.
FT   STRAND      341    349       {ECO:0000244|PDB:2W8N}.
FT   HELIX       350    367       {ECO:0000244|PDB:2W8N}.
FT   STRAND      373    375       {ECO:0000244|PDB:2W8O}.
FT   HELIX       386    400       {ECO:0000244|PDB:2W8N}.
FT   TURN        401    403       {ECO:0000244|PDB:2W8N}.
FT   STRAND      405    408       {ECO:0000244|PDB:2W8N}.
FT   STRAND      423    428       {ECO:0000244|PDB:2W8N}.
FT   HELIX       430    433       {ECO:0000244|PDB:2W8N}.
FT   STRAND      441    450       {ECO:0000244|PDB:2W8N}.
FT   HELIX       452    459       {ECO:0000244|PDB:2W8N}.
FT   STRAND      466    471       {ECO:0000244|PDB:2W8N}.
FT   HELIX       475    484       {ECO:0000244|PDB:2W8N}.
FT   STRAND      487    493       {ECO:0000244|PDB:2W8N}.
FT   HELIX       508    510       {ECO:0000244|PDB:2W8N}.
FT   STRAND      511    513       {ECO:0000244|PDB:2W8N}.
FT   TURN        517    519       {ECO:0000244|PDB:2W8N}.
FT   HELIX       520    524       {ECO:0000244|PDB:2W8N}.
FT   STRAND      525    532       {ECO:0000244|PDB:2W8N}.
SQ   SEQUENCE   535 AA;  57215 MW;  C63A9431D3FA16C7 CRC64;
     MATCIWLRSC GARRLGSTFP GCRLRPRAGG LVPASGPAPG PAQLRCYAGR LAGLSAALLR
     TDSFVGGRWL PAAATFPVQD PASGAALGMV ADCGVREARA AVRAAYEAFC RWREVSAKER
     SSLLRKWYNL MIQNKDDLAR IITAESGKPL KEAHGEILYS AFFLEWFSEE ARRVYGDIIH
     TPAKDRRALV LKQPIGVAAV ITPWNFPSAM ITRKVGAALA AGCTVVVKPA EDTPFSALAL
     AELASQAGIP SGVYNVIPCS RKNAKEVGEA ICTDPLVSKI SFTGSTTTGK ILLHHAANSV
     KRVSMELGGL APFIVFDSAN VDQAVAGAMA SKFRNTGQTC VCSNQFLVQR GIHDAFVKAF
     AEAMKKNLRV GNGFEEGTTQ GPLINEKAVE KVEKQVNDAV SKGATVVTGG KRHQLGKNFF
     EPTLLCNVTQ DMLCTHEETF GPLAPVIKFD TEEEAIAIAN AADVGLAGYF YSQDPAQIWR
     VAEQLEVGMV GVNEGLISSV ECPFGGVKQS GLGREGSKYG IDEYLELKYV CYGGL
//
